Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT.
Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT.
Chest. 2019 May;155(5):938-946. doi: 10.1016/j.chest.2019.02.008. Epub 2019 Feb 16.
The impact of antibiotic timing on sepsis outcomes remains controversial due to conflicting results from previous studies.
This study investigated the association of door-to-antibiotic time with long-term mortality in ED patients with sepsis.
This retrospective cohort study included nontrauma adult ED patients with clinical sepsis admitted to four hospitals from 2013 to 2017. Only patients' first eligible encounter was included. Multivariable logistic regression was used to measure the adjusted association between door-to-antibiotic time and 1-year mortality. Secondary analyses used alternative antibiotic timing measures (antibiotic initiation within 1 or 3 h and separate comparison of antibiotic exposure at each hour up to hour 6), alternative outcomes (hospital, 30-day, and 90-day mortality), and alternative statistical methods to mitigate indication bias.
Among 10,811 eligible patients, median door-to-antibiotic time was 166 min (interquartile range, 115-230 min), and 1-year mortality was 19%. After adjustment, each additional hour from ED arrival to antibiotic initiation was associated with a 10% (95% CI, 5-14; P < .001) increased odds of 1-year mortality. The association remained linear when each 1-h interval of door-to-antibiotic time was independently compared with door-to-antibiotic time ≤ 1 h and was similar for hospital, 30-day, and 90-day mortality. Mortality at 1 year was higher when door-to-antibiotic times were > 3 h vs ≤ 3 h (adjusted OR, 1.27; 95% CI, 1.13-1.43) but not > 1 h vs ≤ 1 h (adjusted OR, 1.26; 95% CI, 0.98-1.62).
Delays in ED antibiotic initiation time are associated with clinically important increases in long-term, risk-adjusted sepsis mortality.
由于先前研究的结果相互矛盾,抗生素时机对脓毒症结局的影响仍存在争议。
本研究旨在探讨急诊科(ED)脓毒症患者的门到抗生素时间与长期死亡率之间的关联。
这是一项回顾性队列研究,纳入了 2013 年至 2017 年期间来自四家医院的临床脓毒症成年 ED 患者。仅纳入患者的首次合格就诊。采用多变量逻辑回归来衡量门到抗生素时间与 1 年死亡率之间的调整关联。次要分析采用替代抗生素时间测量方法(抗生素在 1 小时或 3 小时内开始,分别比较每小时至 6 小时的抗生素暴露情况)、替代结局(医院、30 天和 90 天死亡率)和替代统计方法来减轻指示偏差。
在 10811 名符合条件的患者中,中位数门到抗生素时间为 166 分钟(四分位距,115-230 分钟),1 年死亡率为 19%。调整后,从 ED 到达到抗生素开始的每增加 1 小时,1 年死亡率增加 10%(95%CI,5-14;P<.001)。当每个 1 小时的门到抗生素时间间隔与门到抗生素时间≤1 小时独立比较时,这种关联呈线性,并且与医院、30 天和 90 天死亡率相似。当门到抗生素时间>3 小时与≤3 小时相比时,1 年死亡率更高(调整后的 OR,1.27;95%CI,1.13-1.43),但当门到抗生素时间>1 小时与≤1 小时相比时(调整后的 OR,1.26;95%CI,0.98-1.62)则不然。
ED 抗生素开始时间的延迟与长期、风险调整后脓毒症死亡率的显著增加相关。